Bruker Updates FY 2021 Guidance and Provides Medium Term Outlook at Virtual Investor DayBusiness Wire • 06/17/21
Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay with Mutation Detection for Routine Variant DifferentiationBusiness Wire • 06/07/21
Bruker Launches timsTOF trueSCP for Unbiased Single Cell 4D-Proteomics and Next-gen timsTOF Pro 2 with Unprecedented Proteomic DepthBusiness Wire • 06/01/21
InMode, Idexx Peer Bruker Tests Buy Zone With New Insights Into 'Long Covid'Investors Business Daily • 05/27/21
Bruker's Molecular Phenomics Research Tools Enable New Insights into ‘Long COVID' and Post-Acute Metabolic AbnormalitiesBusiness Wire • 05/20/21
Bruker Announces New Two-Year Share Repurchase Authorization of up to $500 Million; Board also Declares Quarterly DividendBusiness Wire • 05/13/21
International Organization of Vine and Wine (OIV) Officially Incorporates NMR Method in Compendium of International Methods of Analysis of Wines and MustsBusiness Wire • 05/10/21
Bruker Corporation (BRKR) CEO Frank Laukien on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 05/08/21
Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging ResearchBusiness Wire • 03/29/21